Affiliation:
1. ANZAC Research Institute; University of Sydney
Abstract
With the ageing population in most countries, disorders of bone and mineral metabolism are becoming increasingly relevant to every day clinical practice. Consequently, the interest in, and the need for effective measures to be used in the screening, diagnosis and follow-up of such pathologies have markedly grown. Together with clinical and imaging techniques, biochemical tests play an important role in the assessment and differential diagnosis of metabolic bone disease. In recent years, the isolation and characterisation of cellular and extracellular components of the skeletal matrix have resulted in the development of molecular markers that are considered to reflect either bone formation or bone resorption. These biochemical indices are non-invasive, comparatively inexpensive and, when applied and interpreted correctly, helpful tools in the diagnostic and therapeutic assessment of metabolic bone disease. This review provides an overview of the current evidence regarding the clinical use of biochemical markers of bone remodelling in bone disease, with an emphasis on osteoporosis.
Subject
General Medicine,Endocrinology, Diabetes and Metabolism
Reference151 articles.
1. Encyclopaedic Reference of Molecular Pharmacology;Seibel MJ.,2003
2. Encyclopedia of Medicinal Chemistry;Dunstan CR
3. Biochemical markers of bone turnover: Part I: Biochemistry and Variability;Seibel MJ;Clin Biochem Rev,2005
4. Changes with age in the urinary excretion of lysyl- and hydroxylysylpyridinoline, two new markers of bone collagen turnover;Beardsworth LJ;J Bone Miner Res,1990
5. The Tromso Study: a population-based study on the variation in bone formation markers with age, gender, anthropometry and season in both men and women;Midtby M;Osteoporos Int,2001
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献